• レポートコード:D0804-09201 • 出版社/出版日:GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態:英語、PDF、108ページ • 納品方法:Eメール • 産業分類:医療機器・医療消耗品 |
Single User | ¥494,160 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥741,240 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、眼薬物送達システムの世界市場を広く調査・分析し、今後の市場展望をまとめております。眼薬物送達システムの種類別市場規模(埋め込み型眼用薬物送達システム、粒子状薬物送達システム)、用途別市場規模(病院、クリニック、外来手術センター)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Ocular Therapeutix、Taiwan Liposome、Graybug Vision、Alimera Sciences、Santen Pharmaceutical、Allergan、Clearside Biomedical、EyePoint Pharmaceuticals、Bausch Health、Envisia Therapeutics ・地域別グローバル市場分析 2015年-2020年 ・眼薬物送達システムの北米市場(アメリカ、カナダ、メキシコ) ・眼薬物送達システムのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア) ・眼薬物送達システムのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア) ・眼薬物送達システムの南米市場(ブラジル、アルゼンチン) ・眼薬物送達システムの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ) ・種類別分析:埋め込み型眼用薬物送達システム、粒子状薬物送達システム ・用途別分析:病院、クリニック、外来手術センター ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Ocular Drug Delivery System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Ocular Drug Delivery System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Ocular Drug Delivery System market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Ocular Drug Delivery System market has been segmented into
Implantable Ocular Drug Delivery Systems
Particulate Drug Delivery Systems
By Application, Ocular Drug Delivery System has been segmented into:
Hospitals
Clinics
Ambulatory Surgical Centers
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Ocular Drug Delivery System market presented in the report. This section sheds light on the sales growth of different regional and country-level Ocular Drug Delivery System markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Ocular Drug Delivery System market.
The report offers in-depth assessment of the growth and other aspects of the Ocular Drug Delivery System market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Ocular Drug Delivery System Market Share Analysis
Ocular Drug Delivery System competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Ocular Drug Delivery System sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Ocular Drug Delivery System sales, revenue and market share for each player covered in this report.
The major players covered in Ocular Drug Delivery System are:
Ocular Therapeutix
Taiwan Liposome
Graybug Vision
Alimera Sciences
Santen Pharmaceutical
Allergan
Clearside Biomedical
EyePoint Pharmaceuticals
Bausch Health
Envisia Therapeutics
Among other players domestic and global, Ocular Drug Delivery System market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ocular Drug Delivery System product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ocular Drug Delivery System, with price, sales, revenue and global market share of Ocular Drug Delivery System in 2018 and 2019.
Chapter 3, the Ocular Drug Delivery System competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ocular Drug Delivery System breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Ocular Drug Delivery System market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Ocular Drug Delivery System sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Ocular Drug Delivery System Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Ocular Drug Delivery System Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Implantable Ocular Drug Delivery Systems
1.2.3 Particulate Drug Delivery Systems
1.3 Market Analysis by Application
1.3.1 Overview: Global Ocular Drug Delivery System Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Overview of Global Ocular Drug Delivery System Market
1.4.1 Global Ocular Drug Delivery System Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Ocular Therapeutix
2.1.1 Ocular Therapeutix Details
2.1.2 Ocular Therapeutix Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Ocular Therapeutix SWOT Analysis
2.1.4 Ocular Therapeutix Product and Services
2.1.5 Ocular Therapeutix Ocular Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Taiwan Liposome
2.2.1 Taiwan Liposome Details
2.2.2 Taiwan Liposome Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Taiwan Liposome SWOT Analysis
2.2.4 Taiwan Liposome Product and Services
2.2.5 Taiwan Liposome Ocular Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Graybug Vision
2.3.1 Graybug Vision Details
2.3.2 Graybug Vision Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Graybug Vision SWOT Analysis
2.3.4 Graybug Vision Product and Services
2.3.5 Graybug Vision Ocular Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Alimera Sciences
2.4.1 Alimera Sciences Details
2.4.2 Alimera Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Alimera Sciences SWOT Analysis
2.4.4 Alimera Sciences Product and Services
2.4.5 Alimera Sciences Ocular Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Santen Pharmaceutical
2.5.1 Santen Pharmaceutical Details
2.5.2 Santen Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Santen Pharmaceutical SWOT Analysis
2.5.4 Santen Pharmaceutical Product and Services
2.5.5 Santen Pharmaceutical Ocular Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Allergan
2.6.1 Allergan Details
2.6.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Allergan SWOT Analysis
2.6.4 Allergan Product and Services
2.6.5 Allergan Ocular Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Clearside Biomedical
2.7.1 Clearside Biomedical Details
2.7.2 Clearside Biomedical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Clearside Biomedical SWOT Analysis
2.7.4 Clearside Biomedical Product and Services
2.7.5 Clearside Biomedical Ocular Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 EyePoint Pharmaceuticals
2.8.1 EyePoint Pharmaceuticals Details
2.8.2 EyePoint Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 EyePoint Pharmaceuticals SWOT Analysis
2.8.4 EyePoint Pharmaceuticals Product and Services
2.8.5 EyePoint Pharmaceuticals Ocular Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bausch Health
2.9.1 Bausch Health Details
2.9.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bausch Health SWOT Analysis
2.9.4 Bausch Health Product and Services
2.9.5 Bausch Health Ocular Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Envisia Therapeutics
2.10.1 Envisia Therapeutics Details
2.10.2 Envisia Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Envisia Therapeutics SWOT Analysis
2.10.4 Envisia Therapeutics Product and Services
2.10.5 Envisia Therapeutics Ocular Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Ocular Drug Delivery System Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Ocular Drug Delivery System Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Ocular Drug Delivery System Manufacturer Market Share in 2019
3.3.2 Top 6 Ocular Drug Delivery System Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Ocular Drug Delivery System Sales, Revenue and Market Share by Regions
4.1.1 Global Ocular Drug Delivery System Sales and Market Share by Regions (2015-2020)
4.1.2 Global Ocular Drug Delivery System Revenue and Market Share by Regions (2015-2020)
4.2 North America Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
4.3 Europe Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
4.5 South America Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Ocular Drug Delivery System Sales, Revenue and Market Share by Country
5.1.1 North America Ocular Drug Delivery System Sales and Market Share by Country (2015-2020)
5.1.2 North America Ocular Drug Delivery System Revenue and Market Share by Country (2015-2020)
5.2 United States Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
5.3 Canada Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
5.4 Mexico Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Ocular Drug Delivery System Sales, Revenue and Market Share by Country
6.1.1 Europe Ocular Drug Delivery System Sales and Market Share by Country (2015-2020)
6.1.2 Europe Ocular Drug Delivery System Revenue and Market Share by Country (2015-2020)
6.2 Germany Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
6.3 UK Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
6.4 France Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
6.5 Russia Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
6.6 Italy Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Ocular Drug Delivery System Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Ocular Drug Delivery System Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Ocular Drug Delivery System Revenue and Market Share by Regions (2015-2020)
7.2 China Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
7.3 Japan Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
7.4 Korea Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
7.5 India Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
7.7 Australia Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Ocular Drug Delivery System Sales, Revenue and Market Share by Country
8.1.1 South America Ocular Drug Delivery System Sales and Market Share by Country (2015-2020)
8.1.2 South America Ocular Drug Delivery System Revenue and Market Share by Country (2015-2020)
8.2 Brazil Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
8.3 Argentina Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Ocular Drug Delivery System Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Ocular Drug Delivery System Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Ocular Drug Delivery System Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
9.3 Turkey Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
9.4 Egypt Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
9.5 South Africa Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Ocular Drug Delivery System Sales and Market Share by Type (2015-2020)
10.2 Global Ocular Drug Delivery System Revenue and Market Share by Type (2015-2020)
10.3 Global Ocular Drug Delivery System Price by Type (2015-2020)
11 Global Ocular Drug Delivery System Market Segment by Application
11.1 Global Ocular Drug Delivery System Sales Market Share by Application (2015-2020)
11.2 Global Ocular Drug Delivery System Revenue Market Share by Application (2015-2020)
11.3 Global Ocular Drug Delivery System Price by Application (2015-2020)
12 Market Forecast
12.1 Global Ocular Drug Delivery System Sales, Revenue and Growth Rate (2021-2025)
12.2 Ocular Drug Delivery System Market Forecast by Regions (2021-2025)
12.2.1 North America Ocular Drug Delivery System Market Forecast (2021-2025)
12.2.2 Europe Ocular Drug Delivery System Market Forecast (2021-2025)
12.2.3 Asia-Pacific Ocular Drug Delivery System Market Forecast (2021-2025)
12.2.4 South America Ocular Drug Delivery System Market Forecast (2021-2025)
12.2.5 Middle East & Africa Ocular Drug Delivery System Market Forecast (2021-2025)
12.3 Ocular Drug Delivery System Market Forecast by Type (2021-2025)
12.3.1 Global Ocular Drug Delivery System Sales Forecast by Type (2021-2025)
12.3.2 Global Ocular Drug Delivery System Market Share Forecast by Type (2021-2025)
12.4 Ocular Drug Delivery System Market Forecast by Application (2021-2025)
12.4.1 Global Ocular Drug Delivery System Sales Forecast by Application (2021-2025)
12.4.2 Global Ocular Drug Delivery System Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Ocular Drug Delivery System Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Ocular Drug Delivery System by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Ocular Drug Delivery System Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Ocular Therapeutix Basic Information, Manufacturing Base and Competitors
Table 8. Ocular Therapeutix Ocular Drug Delivery System Major Business
Table 9. Ocular Therapeutix Ocular Drug Delivery System Total Revenue (USD Million) (2018-2019)
Table 10. Ocular Therapeutix SWOT Analysis
Table 11. Ocular Therapeutix Ocular Drug Delivery System Product and Services
Table 12. Ocular Therapeutix Ocular Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Taiwan Liposome Basic Information, Manufacturing Base and Competitors
Table 14. Taiwan Liposome Ocular Drug Delivery System Major Business
Table 15. Taiwan Liposome Ocular Drug Delivery System Total Revenue (USD Million) (2018-2019)
Table 16. Taiwan Liposome SWOT Analysis
Table 17. Taiwan Liposome Ocular Drug Delivery System Product and Services
Table 18. Taiwan Liposome Ocular Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Graybug Vision Basic Information, Manufacturing Base and Competitors
Table 20. Graybug Vision Ocular Drug Delivery System Major Business
Table 21. Graybug Vision Ocular Drug Delivery System Total Revenue (USD Million) (2018-2019)
Table 22. Graybug Vision SWOT Analysis
Table 23. Graybug Vision Ocular Drug Delivery System Product and Services
Table 24. Graybug Vision Ocular Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Alimera Sciences Basic Information, Manufacturing Base and Competitors
Table 26. Alimera Sciences Ocular Drug Delivery System Major Business
Table 27. Alimera Sciences Ocular Drug Delivery System Total Revenue (USD Million) (2018-2019)
Table 28. Alimera Sciences SWOT Analysis
Table 29. Alimera Sciences Ocular Drug Delivery System Product and Services
Table 30. Alimera Sciences Ocular Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Santen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 32. Santen Pharmaceutical Ocular Drug Delivery System Major Business
Table 33. Santen Pharmaceutical Ocular Drug Delivery System Total Revenue (USD Million) (2018-2019)
Table 34. Santen Pharmaceutical SWOT Analysis
Table 35. Santen Pharmaceutical Ocular Drug Delivery System Product and Services
Table 36. Santen Pharmaceutical Ocular Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Allergan Basic Information, Manufacturing Base and Competitors
Table 38. Allergan Ocular Drug Delivery System Major Business
Table 39. Allergan Ocular Drug Delivery System Total Revenue (USD Million) (2018-2019)
Table 40. Allergan SWOT Analysis
Table 41. Allergan Ocular Drug Delivery System Product and Services
Table 42. Allergan Ocular Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Clearside Biomedical Basic Information, Manufacturing Base and Competitors
Table 44. Clearside Biomedical Ocular Drug Delivery System Major Business
Table 45. Clearside Biomedical Ocular Drug Delivery System Total Revenue (USD Million) (2018-2019)
Table 46. Clearside Biomedical SWOT Analysis
Table 47. Clearside Biomedical Ocular Drug Delivery System Product and Services
Table 48. Clearside Biomedical Ocular Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. EyePoint Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 50. EyePoint Pharmaceuticals Ocular Drug Delivery System Major Business
Table 51. EyePoint Pharmaceuticals Ocular Drug Delivery System Total Revenue (USD Million) (2018-2019)
Table 52. EyePoint Pharmaceuticals SWOT Analysis
Table 53. EyePoint Pharmaceuticals Ocular Drug Delivery System Product and Services
Table 54. EyePoint Pharmaceuticals Ocular Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 56. Bausch Health Ocular Drug Delivery System Major Business
Table 57. Bausch Health Ocular Drug Delivery System Total Revenue (USD Million) (2018-2019)
Table 58. Bausch Health SWOT Analysis
Table 59. Bausch Health Ocular Drug Delivery System Product and Services
Table 60. Bausch Health Ocular Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Envisia Therapeutics Basic Information, Manufacturing Base and Competitors
Table 62. Envisia Therapeutics Ocular Drug Delivery System Major Business
Table 63. Envisia Therapeutics Ocular Drug Delivery System Total Revenue (USD Million) (2018-2019)
Table 64. Envisia Therapeutics SWOT Analysis
Table 65. Envisia Therapeutics Ocular Drug Delivery System Product and Services
Table 66. Envisia Therapeutics Ocular Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Ocular Drug Delivery System Sales by Manufacturer (2018-2019) (K Units)
Table 68. Global Ocular Drug Delivery System Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Ocular Drug Delivery System Sales by Regions (2015-2020) (K Units)
Table 70. Global Ocular Drug Delivery System Sales Market Share by Regions (2015-2020)
Table 71. Global Ocular Drug Delivery System Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Ocular Drug Delivery System Sales by Countries (2015-2020) (K Units)
Table 73. North America Ocular Drug Delivery System Sales Market Share by Countries (2015-2020)
Table 74. North America Ocular Drug Delivery System Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Ocular Drug Delivery System Revenue Market Share by Countries (2015-2020)
Table 76. Europe Ocular Drug Delivery System Sales by Countries (2015-2020) (K Units)
Table 77. Europe Ocular Drug Delivery System Sales Market Share by Countries (2015-2020)
Table 78. Europe Ocular Drug Delivery System Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Ocular Drug Delivery System Sales by Regions (2015-2020) (K Units)
Table 80. Asia-Pacific Ocular Drug Delivery System Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Ocular Drug Delivery System Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Ocular Drug Delivery System Sales by Countries (2015-2020) (K Units)
Table 83. South America Ocular Drug Delivery System Sales Market Share by Countries (2015-2020)
Table 84. South America Ocular Drug Delivery System Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Ocular Drug Delivery System Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Ocular Drug Delivery System Sales by Countries (2015-2020) (K Units)
Table 87. Middle East & Africa Ocular Drug Delivery System Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Ocular Drug Delivery System Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Ocular Drug Delivery System Revenue Market Share by Countries (2015-2020)
Table 90. Global Ocular Drug Delivery System Sales by Type (2015-2020) (K Units)
Table 91. Global Ocular Drug Delivery System Sales Share by Type (2015-2020)
Table 92. Global Ocular Drug Delivery System Revenue by Type (2015-2020) (USD Million)
Table 93. Global Ocular Drug Delivery System Revenue Share by Type (2015-2020)
Table 94. Global Ocular Drug Delivery System Sales by Application (2015-2020) (K Units)
Table 95. Global Ocular Drug Delivery System Sales Share by Application (2015-2020)
Table 96. Global Ocular Drug Delivery System Sales Forecast by Regions (2021-2025) (K Units)
Table 97. Global Ocular Drug Delivery System Market Share Forecast by Regions (2021-2025)
Table 98. Global Ocular Drug Delivery System Sales Forecast by Type (2021-2025) (K Units)
Table 99. Global Ocular Drug Delivery System Market Share Forecast by Type (2021-2025)
Table 100. Global Ocular Drug Delivery System Sales Forecast by Application (2021-2025)
Table 101. Global Ocular Drug Delivery System Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Ocular Drug Delivery System Picture
Figure 2. Global Sales Market Share of Ocular Drug Delivery System by Type in 2019
Figure 3. Implantable Ocular Drug Delivery Systems Picture
Figure 4. Particulate Drug Delivery Systems Picture
Figure 5. Ocular Drug Delivery System Sales Market Share by Application in 2018
Figure 6. Hospitals Picture
Figure 7. Clinics Picture
Figure 8. Ambulatory Surgical Centers Picture
Figure 9. Global Ocular Drug Delivery System Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Ocular Drug Delivery System Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Ocular Drug Delivery System Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Ocular Drug Delivery System Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Ocular Drug Delivery System Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Ocular Drug Delivery System Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Ocular Drug Delivery System Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Ocular Drug Delivery System Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Ocular Drug Delivery System Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Ocular Drug Delivery System Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Ocular Drug Delivery System Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Ocular Drug Delivery System Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Ocular Drug Delivery System Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Ocular Drug Delivery System Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Ocular Drug Delivery System Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Ocular Drug Delivery System Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Ocular Drug Delivery System Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Ocular Drug Delivery System Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Ocular Drug Delivery System Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Ocular Drug Delivery System Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Ocular Drug Delivery System Sales Market Share by Manufacturer in 2019
Figure 30. Global Ocular Drug Delivery System Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Ocular Drug Delivery System Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Ocular Drug Delivery System Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Ocular Drug Delivery System Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Ocular Drug Delivery System Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Ocular Drug Delivery System Revenue Market Share by Regions (2015-2020)
Figure 37. Global Ocular Drug Delivery System Revenue Market Share by Regions in 2018
Figure 38. North America Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
Figure 39. Europe Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
Figure 41. South America Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Ocular Drug Delivery System Sales and Growth Rate (2015-2020)
Figure 43. North America Ocular Drug Delivery System Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Ocular Drug Delivery System Sales Market Share by Countries (2015-2020)
Figure 45. North America Ocular Drug Delivery System Sales Market Share by Countries in 2018
Figure 46. North America Ocular Drug Delivery System Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Ocular Drug Delivery System Revenue Market Share by Countries in 2018
Figure 48. United States Ocular Drug Delivery System Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Ocular Drug Delivery System Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Ocular Drug Delivery System Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Ocular Drug Delivery System Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Ocular Drug Delivery System Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Ocular Drug Delivery System Revenue Market Share by Countries in 2019
Figure 54. Germany Ocular Drug Delivery System Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Ocular Drug Delivery System Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Ocular Drug Delivery System Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Ocular Drug Delivery System Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Ocular Drug Delivery System Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Ocular Drug Delivery System Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Ocular Drug Delivery System Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Ocular Drug Delivery System Revenue Market Share by Regions 2019
Figure 62. China Ocular Drug Delivery System Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Ocular Drug Delivery System Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Ocular Drug Delivery System Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Ocular Drug Delivery System Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Ocular Drug Delivery System Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Ocular Drug Delivery System Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Ocular Drug Delivery System Sales Market Share by Countries in 2019
Figure 69. South America Ocular Drug Delivery System Revenue Market Share by Countries in 2019
Figure 70. Brazil Ocular Drug Delivery System Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Ocular Drug Delivery System Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Ocular Drug Delivery System Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Ocular Drug Delivery System Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Ocular Drug Delivery System Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Ocular Drug Delivery System Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Ocular Drug Delivery System Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Ocular Drug Delivery System Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Ocular Drug Delivery System Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Ocular Drug Delivery System Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Ocular Drug Delivery System Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Ocular Drug Delivery System Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Ocular Drug Delivery System Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Ocular Drug Delivery System Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Ocular Drug Delivery System Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Ocular Drug Delivery System Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Ocular Drug Delivery System Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel